Full Press Release Details
IRVINE, CA--(Marketwire - January 20, 2010) - Biomerica, Inc. (OTCBB: BMRA) today reported net
sales of $1,099,880 for the three months ended November 30, 2009, compared
to $1,120,575 for the same period in the previous year. Net sales were
$2,248,401 for the first six months of fiscal 2010 compared to $2,314,920
for the first six months in fiscal 2009.
Biomerica announced net loss for the three months ended November 30, 2009,
of $305,706 versus a net loss of $103,016 in the previous fiscal year
during the same quarter. The net loss for the six months ended November
30, 2009 was $297,772, compared to net income of $37,796 in the same period
the previous fiscal year. The increase in losses was primarily due to
non-recurring move expenses associated with the move to a new building.
"Through careful planning and coordination, we have moved into our new
state of the art facility that provides work flow and efficiencies
unattainable at our old Newport Beach facility. We accomplished our move
and met all regulatory requirements while providing our customers seamless
and uninterrupted service," stated Zackary Irani, Biomerica CEO.
About Biomerica (OTCBB: BMRA)
Biomerica, Inc. (www.biomerica.com) is a global medical technology company,
based in Irvine, CA. The Company's diagnostics division manufactures and
markets advanced diagnostic products used at home, in hospitals, and in
physicians' offices for the early detection of medical conditions and
The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements. Certain information included in
this press release (as well as information included in oral statements or
other written statements made or to be made by Biomerica) contains
statements that are forward-looking; such as statements relating to
intended launch dates, sales potential, significant benefits, market size,
growth prospects, new products, favorable positions, new distributors,
expansion, increases in productivity and margins, expected orders, leading
market positions, anticipated future revenues or production volume of the
Company, success of product and new product offerings. Such forward-looking
information involves important risks and uncertainties that could
significantly affect anticipated results in the future, and accordingly,
such results may differ materially from those expressed in any
forward-looking statements made by or on behalf of Biomerica. The potential
risks and uncertainties include, among others, fluctuations in the
Company's operating results due to its business model and expansion plans,
downturns in international and or national economies, the Company's ability
to raise additional capital, the competitive environment in which the
Company will be competing, and the Company's dependence on strategic
relationships. The Company is under no obligation to update any
forward-looking statements after the date of this release.
Contact Information: Contact: